Immediate Impact

3 by Nobel laureates 29 from Science/Nature 70 standout
Sub-graph 1 of 22

Citing Papers

Natural killer cell therapies
2024 StandoutNature
Hallmarks of aging: An expanding universe
2023 Standout
2 intermediate papers

Works of Bridget O’Keeffe being referenced

A phase III randomized open label study comparing bempegaldesleukin (NKTR-214) plus nivolumab to sunitinib or cabozantinib (investigator's choice) in patients with previously untreated advanced renal cell carcinoma.
2019
The serum- and glucocorticoid-induced protein kinase-1 (Sgk-1) mitochondria connection: Identification of the IF-1 inhibitor of the F1F0-ATPase as a mitochondria-specific binding target and the stress-induced mitochondrial localization of endogenous Sgk-1
2013

Author Peers

Author Last Decade Papers Cites
Bridget O’Keeffe 88 116 522 92 13 730
D E Pollet 57 85 217 29 16 581
Huanchun Zhang 34 64 468 138 20 652
Tapati Maity 184 127 554 126 14 763
John Armstrong 45 103 221 138 19 809
Enrica Bellesia 65 103 434 132 13 763
Erik R. Kline 53 190 375 180 13 815
Emily N. Chin 52 99 467 144 19 820
R Misra 26 94 545 63 16 823
Adriana Gallo 20 105 451 29 21 695
Steve Mohr 136 118 356 153 12 714

All Works

Loading papers...

Rankless by CCL
2026